Logo image of M5Z.DE

MANZ AG (M5Z.DE) Stock Fundamental Analysis

FRA:M5Z - Deutsche Boerse Ag - DE000A0JQ5U3 - Common Stock - Currency: EUR

1.165  -0.24 (-17.38%)

Fundamental Rating

1

Overall M5Z gets a fundamental rating of 1 out of 10. We evaluated M5Z against 54 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of M5Z have multiple concerns. M5Z does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

M5Z had negative earnings in the past year.
M5Z had a negative operating cash flow in the past year.
In the past 5 years M5Z reported 4 times negative net income.
In the past 5 years M5Z reported 4 times negative operating cash flow.
M5Z.DE Yearly Net Income VS EBIT VS OCF VS FCFM5Z.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -14.02%, M5Z is not doing good in the industry: 97.83% of the companies in the same industry are doing better.
With a Return On Equity value of -49.27%, M5Z is not doing good in the industry: 93.48% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -14.02%
ROE -49.27%
ROIC N/A
ROA(3y)-4.08%
ROA(5y)-2.9%
ROE(3y)-13.48%
ROE(5y)-9.24%
ROIC(3y)N/A
ROIC(5y)N/A
M5Z.DE Yearly ROA, ROE, ROICM5Z.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40 -50

1.3 Margins

In the last couple of years the Operating Margin of M5Z has grown nicely.
Looking at the Gross Margin, with a value of 45.24%, M5Z is doing worse than 65.22% of the companies in the same industry.
M5Z's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for M5Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.24%
OM growth 3Y11.31%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.28%
GM growth 5Y4.44%
M5Z.DE Yearly Profit, Operating, Gross MarginsM5Z.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

M5Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
M5Z has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, M5Z has more shares outstanding
Compared to 1 year ago, M5Z has a worse debt to assets ratio.
M5Z.DE Yearly Shares OutstandingM5Z.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
M5Z.DE Yearly Total Debt VS Total AssetsM5Z.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

M5Z has an Altman-Z score of 0.76. This is a bad value and indicates that M5Z is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.76, M5Z is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.32 indicates that M5Z is not too dependend on debt financing.
M5Z's Debt to Equity ratio of 0.32 is in line compared to the rest of the industry. M5Z outperforms 41.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 0.76
ROIC/WACCN/A
WACC6.09%
M5Z.DE Yearly LT Debt VS Equity VS FCFM5Z.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

M5Z has a Current Ratio of 1.06. This is a normal value and indicates that M5Z is financially healthy and should not expect problems in meeting its short term obligations.
M5Z has a Current ratio of 1.06. This is amonst the worse of the industry: M5Z underperforms 89.13% of its industry peers.
A Quick Ratio of 0.86 indicates that M5Z may have some problems paying its short term obligations.
M5Z has a worse Quick ratio (0.86) than 80.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.86
M5Z.DE Yearly Current Assets VS Current LiabilitesM5Z.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for M5Z have decreased strongly by -3712.14% in the last year.
Looking at the last year, M5Z shows a very negative growth in Revenue. The Revenue has decreased by -26.20% in the last year.
Measured over the past years, M5Z shows a decrease in Revenue. The Revenue has been decreasing by -3.45% on average per year.
EPS 1Y (TTM)-3712.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2228.68%
Revenue 1Y (TTM)-26.2%
Revenue growth 3Y1.72%
Revenue growth 5Y-3.45%
Sales Q2Q%-33.67%

3.2 Future

M5Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.98% yearly.
M5Z is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.94% yearly.
EPS Next Y-1042.22%
EPS Next 2Y-68.66%
EPS Next 3Y69.98%
EPS Next 5YN/A
Revenue Next Year-21.96%
Revenue Next 2Y-5.97%
Revenue Next 3Y0.43%
Revenue Next 5Y1.94%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
M5Z.DE Yearly Revenue VS EstimatesM5Z.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
M5Z.DE Yearly EPS VS EstimatesM5Z.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for M5Z. In the last year negative earnings were reported.
Also next year M5Z is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
M5Z.DE Price Earnings VS Forward Price EarningsM5Z.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
M5Z.DE Per share dataM5Z.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as M5Z's earnings are expected to grow with 69.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.66%
EPS Next 3Y69.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for M5Z!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANZ AG

FRA:M5Z (12/27/2024, 7:00:00 PM)

1.165

-0.24 (-17.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-28 2024-11-28
Earnings (Next)N/A N/A
Inst Owners8.26%
Inst Owner ChangeN/A
Ins Owners22.71%
Ins Owner ChangeN/A
Market Cap11.94M
Analysts47.5
Price Target1.94 (66.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-62.38%
PT rev (3m)-62.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-27.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-4.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-1.39
OCFYN/A
SpS18.33
BVpS6.87
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.02%
ROE -49.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.24%
FCFM N/A
ROA(3y)-4.08%
ROA(5y)-2.9%
ROE(3y)-13.48%
ROE(5y)-9.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y11.31%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.28%
GM growth 5Y4.44%
F-Score1
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 220.56%
Cap/Sales 12.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.86
Altman-Z 0.76
F-Score1
WACC6.09%
ROIC/WACCN/A
Cap/Depr(3y)185.81%
Cap/Depr(5y)137.97%
Cap/Sales(3y)10.39%
Cap/Sales(5y)7.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3712.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2228.68%
EPS Next Y-1042.22%
EPS Next 2Y-68.66%
EPS Next 3Y69.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.2%
Revenue growth 3Y1.72%
Revenue growth 5Y-3.45%
Sales Q2Q%-33.67%
Revenue Next Year-21.96%
Revenue Next 2Y-5.97%
Revenue Next 3Y0.43%
Revenue Next 5Y1.94%
EBIT growth 1Y-474.13%
EBIT growth 3Y13.22%
EBIT growth 5YN/A
EBIT Next Year-36.63%
EBIT Next 3Y78.5%
EBIT Next 5YN/A
FCF growth 1Y-21.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.2%
OCF growth 3YN/A
OCF growth 5YN/A